Emilia Arjona

发表

Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein

S. Ołdziej, M. Okrój, S. Rodríguez de Córdoba, 2021, Frontiers in Immunology.

Eculizumab in secondary atypical haemolytic uraemic syndrome

T. Cavero, S. Rodríguez de Córdoba, P. Aljama, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer–Simons syndrome)

F. Villarroya, F. Santini, G. Ceccarini, 2021, International journal of molecular sciences.

Gain-of-function mutation in complement C2 protein identified in patient with aHUS.

S. Ołdziej, E. Volokhina, A. Blom, 2020, The Journal of allergy and clinical immunology.

Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.

T. Cavero, S. Rodríguez de Córdoba, L. Quintana, 2019, Kidney international.

Is the atypical hemolytic uremic syndrome risk polymorphism in Membrane Cofactor Protein MCPggaac relevant in kidney transplantation? A case report

A. Sánchez-Moreno, S. D. de Córdoba, R. Bedoya, 2020, Pediatric transplantation.

The familial risk of developing atypical Hemolytic Uremic Syndrome.

S. Rodríguez de Córdoba, E. Goicoechea de Jorge, A. Huerta, 2020, Blood.

Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury

S. Rodríguez de Córdoba, Á. Alonso, S. Pita, 2018, American Journal of Nephrology.

Characteristics, management and outcomes of atypical haemolytic uraemic syndrome in kidney transplant patients: a retrospective national study

T. Cavero, S. Rodríguez de Córdoba, F. Diekmann, 2020, Clinical kidney journal.

Complement Genetic Variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome

P. Sánchez-Corral, Á. Szilágyi, Z. Prohászka, 2021, Frontiers in Immunology.

A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.

T. Cavero, S. Rodríguez de Córdoba, M. Blasco, 2017, Kidney international.

Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.

G. Remuzzi, S. Rodríguez de Córdoba, E. Goicoechea de Jorge, 2017, Journal of the American Society of Nephrology : JASN.

Substitutions at position 263 within the von Willebrand factor type A domain determine the functionality of complement C2 protein

S. Ołdziej, M. Okrój, S. Rodríguez de Córdoba, 2022, Frontiers in Immunology.

Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification

G. Del Angel, Rui-Ru Ji, S. Rodríguez de Córdoba, 2021, Blood.

Complete functional characterization of disease-associated genetic variants in the complement factor H gene.

S. Rodríguez de Córdoba, A. Tortajada, J. García-Fernández, 2017, Kidney international.

Thrombotic microangiopathy in patients with malignant hypertension.

T. Cavero, S. Rodríguez de Córdoba, E. Goicoechea de Jorge, 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Relevance of the MCP Risk Polymorphism to the Outcome of aHUS Associated With C3 Mutations. A Case Report

S. Rodríguez de Córdoba, Emilia Arjona, M. Subias, 2020, Frontiers in Immunology.

T. Cavero, P. Sánchez-Corral, Emilia Arjona, 2020, Clinical kidney journal.

On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome.

T. Cavero, S. Rodríguez de Córdoba, M. Blasco, 2023, Kidney international.